Role of kinins in the endothelial protective effect of ischaemic preconditioning

British Journal of Pharmacology

Volumn 123, Issue 3, 1998, Pages 413-420

  Bouchard, Jean François ^a,b   Chouinard, Jérôme ^a   Lamontagne, Daniel ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b FRSQ ^*

Author keywords

Coronary circulation; Endothelium; Ischaemic preconditioning; Kinins

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; ICATIBANT; KININ; NITROPRUSSIDE SODIUM; SEROTONIN;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY VASCULAR RESISTANCE; HEART INFARCTION PREVENTION; ISOLATED HEART; MALE; NONHUMAN; PERFUSION; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VASODILATATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; BRADYKININ; ENDOTHELIUM, VASCULAR; HEART; ISCHEMIC PRECONDITIONING; KININS; MALE; MYOCARDIAL ISCHEMIA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, BRADYKININ; VASCULAR RESISTANCE;

EID: 0031974939     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701619     Document Type: Article

References (37)

1. 2 may activate ATP sensitive potassium channels in the isolated rat heart. Cardiovasc. Res., 28, 901-905.
2. BOUCHARD, J.-F., LAMONTAGNE, D. (1996). Mechanisms of protection afforded by preconditioning to endothelial function against ischemic injury. Am. J. Physiol., 271, H1801-H1806.
3. BREW, E.C., MITCHELL, M.B., REHRING, T.F., GAMBONI-ROBERTSON, F., MCINTYRE, R.C., JR., HARKEN, A.H., BANERJEE, A. (1995). Role of bradykinin in cardiac functional protection after global ischemia-reperfusion in rat heart. Am. J. Physiol., 269, H1370-H1378.
4. 1 receptor. Br. J. Pharmacol., 108, 318-322.
5. COHEN, M.V., LIU, G.S., DOWNEY, J.M. (1991). Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation, 84, 341-349.
6. DEFILY, D.V., CHILIAN, W.M. (1993). Preconditioning protects coronary arteriolar endothelium from ischemia-reperfusion injury. Am. J. Physiol., 265, H700-H706.
7. 1 receptor-related peptides: antagonists. Hypertension, 28, 833-839.
8. GOTO, M., LIU, Y.G., YANG, X.M., ARDELL, J.L., COHEN, M.V., DOWNEY, J.M. (1995). Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ. Res., 77, 611-621.
9. GROVER, G.J. (1994). Protective effects of ATP sensitive potassium channel openers in models of myocardial ischemia. Cardiovasc. Res., 28, 778-782.
10. HAGAR, J.M., HALE, S.L., KLONER, R.A. (1991). Effects of preconditioning ischemia on reperfusion arrhythmias after coronary artery occlusion and reperfusion in the rat. Circ. Res., 68, 61-68.
11. LI, Y., KLONER, R.A. (1992). Cardioprotective effects of ischaemic preconditioning are not mediated by prostanoids. Cardiovasc. Res., 26, 226-231.
12. LINZ, W., MARTORANA, P.A., SCHÖLKENS, B.A. (1990). Local inhibition of bradykinin degradation in ischemic hearts. J. Cardiovasc. Pharmacol., 15 (Suppl 6), S99-S109.
13. LINZ, W., WIEMER, G., GOHLKE, P., UNGER, T., SCHÖLKENS, B.A. (1995). Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol. Rev., 47, 25-49.
14. LINZ, W., WIEMER, G., SCHÖLKENS, B.A. (1996). Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies. Diabetes, 45 (Suppl 1), S51-S58.
15. 3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart. Cardiovasc. Res., 28, 1057-1061.
16. MANKAD, P.S., CHESTER, A.H., YACOUB, M.H. (1991). 5-Hydroxytryptamine mediates endothelium dependent coronary vasodilatation in the isolated rat heart by the release of nitric oxide. Cardiovasc. Res., 25, 244-248.
17. 1 type and their antagonists. In Bradykinin Antagonists: Basic and Clinical Research, ed. Burch, R.M. 33-49. New York: Marcel Dekker.
18. MITCHELL, M.B., MENG, X., AO, L., BROWN, J.M., HARKEN, A.H., BANERJEE, A. (1995). Preconditioning of isolated rat heart is mediated by protein kinase C. Circ. Res., 76, 73-81.
19. MIURA, T., IIMURA, O. (1993). Infarct size limitation by preconditioning: its phenomenological features and the key role of adenosine. Cardiovasc. Res., 27, 36-42.
20. + channel of vascular smooth muscle cells. FEBS Lett., 345, 47-49.
21. MURRY, C.E., JENNINGS, R.B., REIMER, K.A. (1986). Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation, 74, 1124-1136.
22. MURRY, C.E., RICHARD, V.J., REIMER, K.A., JENNINGS, R.B. (1990). Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ. Res., 66, 913-931.
23. ATP channels in ischaemic preconditioning. Cardiovasc. Res., 28, 783-787.
24. PARRATT, J.R., VEGH, A., PAPP, J.G. (1995). Bradykinin as an endogenous myocardial protective substance with particular reference to ischemic preconditioning: a brief review of the evidence. Can. J. Physiol. Pharmacol., 73, 837-842.
25. PEARSON, P.J., SCHAFF, H.V., VANHOUTTE, P.M. (1990). Acute impairment of endothelium-dependent relaxations to aggregating platelets following reperfusion injury in canine coronary arteries. Circ. Res., 67, 385-393.
26. REGOLI, D., CALO, G., RIZZI, A. BOGONI, G, GOBEIL, F., CAMPOBASSO, C., MOLLICA, G., BEANI, L. (1996). Bradykinin receptors and receptor ligands (with special emphasis on vascular receptors). Regul. Pept., 65, 83-89.
27. REIMER, K.A., VANDER HEIDE, R.S., JENNINGS, R.B. (1994). Ischemic preconditioning slows ischemic metabolism and limits myocardial infarct size. Ann. New York Acad. Sci., 723, 99-115.
28. RICHARD, V., KAEFFER, N., TRON, C., THUILLEZ, C. (1994). Ischemic preconditioning protects against coronary endothelial dysfunction induced by ischemia and reperfusion. Circulation, 89, 1254-1261.
29. SACK, S., MOHRI, M., ARRAS, M., SCHWARZ, E.R., SCHAPER, W. (1993). Ischaemic preconditioning: time course of renewal in the pig. Cardiovasc. Res., 27, 551-555.
30. SHIKI, K., HEARSE, D.J. (1987). Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias. Am. J. Physiol., 253, H1470-H1476.
31. SPEECHLY-DICK, M.E., MOCANU, M.M., YELLON, D.M. (1994). Protein kinase C. Its role in ischemic preconditioning in the rat. Circ. Res., 75, 586-590.
32. VAN BENTHUYSEN, K.M., MCMURTRY, I.F., HORWITZ, L.D. (1987). Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro. J. Clin. Invest., 79, 265-274.
33. VEGH, A., SZEKERES, L., PARRATT, J.R. (1991). Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs. Br. J. Pharmacol., 104, 294-295.
34. 2 receptors. Br. J. Pharmacol., 113, 1167-1172.
35. WALL, T.M., SHEEHY, R., HARTMAN, J.C. (1994). Role of bradykinin in myocardial preconditioning. J. Pharmacol. Exp. Ther., 270, 681-689.
36. YELLON, D.M., ALKHULAIFI, A.M., BROWNE, E.E., PUGSLEY, W.B. (1992). Ischaemic preconditioning limits infarct size in the rat heart. Cardiovasc. Res., 26, 983-987.
37. YELLON, D.M., ALKHULAIFI, A.M., PUGSLEY, W.B. (1993). Preconditioning the human myocardium. Lancet, 342, 276-277.